BlackRock, Inc. 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 31,238 2.100% | -63,952 (-67.18%) | Filing |
| 2023-02-06 3:34 pm Purchase | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 95,190 6.500% | 12,758 (+15.48%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 82,432 7.300% | 3,256 (+4.11%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 79,176 7.300% | 16,186 (+25.70%) | Filing |